Pregnancy, prescription medicines and the potential risk of herb-drug interactions: a cross-sectional survey
- PMID: 29258478
- PMCID: PMC5738179
- DOI: 10.1186/s12906-017-2052-1
Pregnancy, prescription medicines and the potential risk of herb-drug interactions: a cross-sectional survey
Abstract
Background: Pregnant women are routinely prescribed medicines while self-medicating with herbal natural products to treat predominantly pregnancy related conditions. The aim of this study was to assess the potential for herb-drug interactions (HDIs) in pregnant women and to explore possible herb-drug interactions and their potential clinical significance.
Methods: A cross-sectional survey of women during early pregnancy or immediately postpartum in North-East Scotland. Outcome measures included; Prescription medicines use excluding vitamins and potential HDIs assessed using Natural Medicines Comprehensive Database.
Results: The survey was completed by 889 respondents (73% response rate). 45.3% (403) reported the use of at least one prescription medicine, excluding vitamins. Of those taking prescription medicines, 44.9% (181) also reported concurrent use of at least one HNP (Range 1-12). A total of 91 different prescription medicines were reported by respondents using HNPs. Of those taking prescription medicines, 44.9% (181) also reported concurrent use of at least one HNP (Range 1-12). Thirty-four herb-drug interactions were identified in 23 (12.7%) women with the potential to increase the risk of postpartum haemorrhage, alter maternal haemodynamics, and enhance maternal/fetal CNS depression. Almost all were rated as moderate (93.9%), one as a potentially major (ginger and nifedipine) and only one minor (ondansetron and chamomile).
Conclusion: Almost half of pregnant women in this study were prescribed medicines excluding vitamins and minerals and almost half of these used HNPs. Potential moderate to severe HDIs were identified in an eighth of the study cohort. Healthcare professionals should be aware that the concurrent use of HNPs and prescription medicines during pregnancy is common and carries potential risks.
Keywords: Antenatal; Botanical; Female; Herb-drug interaction; Herbal; Postnatal; Pregnancy; Surveys and questionnaires.
Conflict of interest statement
Ethics approval and consent to participate
This research was approved by National Health Service North of Scotland Research Ethics Committee and National Health Service Grampian Research and Development Committee on June 27, 2011 (REC 11/ AL/0094). As the Ethics Committee required the survey questionnaires to be fully anonymous and returned directly by respondents in post-paid envelopes with no record of identifiable data, written consent to participate was deemed unnecessary.
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey.Altern Ther Health Med. 2007 Mar-Apr;13(2):30-5. Altern Ther Health Med. 2007. PMID: 17405676
-
The prevalence of herbs use in conjunction with conventional medicines in Jamaica.Complement Ther Med. 2010 Feb;18(1):13-20. doi: 10.1016/j.ctim.2010.01.002. Epub 2010 Feb 7. Complement Ther Med. 2010. PMID: 20178874
-
Vitamin and herbal extracts use in patients diagnosed with dementia: what do health professionals know and think?Aging Ment Health. 2011 Mar;15(2):267-71. doi: 10.1080/13607863.2010.513040. Epub 2010 Dec 6. Aging Ment Health. 2011. PMID: 21140309
-
The use of botanicals during pregnancy and lactation.Altern Ther Health Med. 2009 Jan-Feb;15(1):54-8. Altern Ther Health Med. 2009. PMID: 19161049 Review.
-
Herb-drug interactions: interactions between kava and prescription medications.Geriatrics. 2005 Sep;60(9):24-5. Geriatrics. 2005. PMID: 16153141 Review.
Cited by
-
Phytotherapy in obstetrics - therapeutic indications, limits, and dangers.J Med Life. 2021 Nov-Dec;14(6):748-755. doi: 10.25122/jml-2021-0353. J Med Life. 2021. PMID: 35126743 Free PMC article. Review.
-
Prevalence of drug-herb and drug-supplement interactions in older adults: a cross-sectional survey.Br J Gen Pract. 2018 Oct;68(675):e711-e717. doi: 10.3399/bjgp18X699101. Br J Gen Pract. 2018. PMID: 30249608 Free PMC article.
-
Mothers of children with Down syndrome: a clinical and epidemiological study.J Community Genet. 2023 Apr;14(2):189-195. doi: 10.1007/s12687-022-00627-7. Epub 2022 Dec 23. J Community Genet. 2023. PMID: 36562914 Free PMC article.
-
Real-world Evidence of the Herb-drug Interactions.J Food Drug Anal. 2022 Sep 15;30(3):316-330. doi: 10.38212/2224-6614.3428. J Food Drug Anal. 2022. PMID: 39666292 Free PMC article. Review.
-
Drug transport across the human placenta: review of placenta-on-a-chip and previous approaches.Interface Focus. 2019 Oct 6;9(5):20190031. doi: 10.1098/rsfs.2019.0031. Epub 2019 Aug 16. Interface Focus. 2019. PMID: 31485316 Free PMC article. Review.
References
-
- Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report; Hyattsville, MD: 2008. Natl Health Stat Report; no 12. - PubMed
-
- AARP NCCAM. Complementary and alternative medicine: what people aged 50 and older discuss with their health care providers. Consumer Survey Report. 2011, pp. 1–14
-
- Eardley S, Bishop FL, Prescott P, Cardini F, Brinkhaus B, Santos-Rey K, et al. A systematic literature review of complementary and alternative medicine prevalence in EU. Forsch Komplementmed. 2012;19(Suppl 2):18–28. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical